Category: CNS/Neurology
Europe CNS/Neurology
-
Cell Therapy Market, By Therapy Type (Stem Cells, T-cells, Dendritic Cells, NK-cells), By Indication (Oncology, Cardiology, Neurology, Others), By End User (Hospitals, Clinics, Research Institutes), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... East & Africa) Global cell therapy market is expected to witness growth substantially over the next decade due to rising prevalence of chronic diseases coupled with increasing geriatric population globally. Cell therapy is an emerging ... Read More
-
Spinal Muscular Atrophy Market, by Type (Type I, Type II, Type III, and Type IV), by Treatment (Gene Therapy and Disease-modifying drugs), by Age Group (Infant and Adult), by Route of Administration (Oral and Injectables), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
... by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031 Spinal ... Read More
-
Gene Therapy Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Vectors (Non-Viral Vectors and Viral Vectors), Indication (Neurological Diseases, Cancer, Duchenne Muscular Dystrophy, Hepatological Diseases, and Other Indications), Delivery Mode (In-Vivo and Ex-Vivo), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... Diseases, and Other Indications), Delivery Mode (In-Vivo and Ex-Vivo), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) The gene therapy market size is expected to grow from ... Read More
-
Sweden Neurology Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... The COVID-19 pandemic significantly impacted neurology care in Sweden during the early phase, which also impacted the usage of neurology devices. For instance, according to an article published by PubMed in January 2023, a study ... Read More
-
Global Blarcamesine Market, By Route of Adminsitration (Oral, Parenteral), By Application (Alzheimer's Disease, Parkinson's Disease , Dementia, Rett Syndrome, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
... Pacific, Latin America, Middle East and Africa). Global blarcamesin market will be valued at US$ 822.2 Mn in 2026 and is expected to reach US$ 992.4 Mn by 2031, exhibiting a compound annual growth rate ... Read More
-
Peripheral Nerve Stimulators Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... The prevalence of neurologic disorders continues to rise, affecting approximately 50 million Americans annually, according to data from the National Institute of Neurological Disorders and Stroke. Neuropathic pain, a common issue in industrialized nations, impacts ... Read More
-
Therapeutic Hypothermia Systems Market by Product (Cooling Devices, Cooling Catheters, Cool Caps), Application (Neurology, Cardiology, Neonatal Care), and Region (North America, Europe, Asia- Pacific, RoW) - Global Forecast to 2028
... market is projected to reach USD 396 million by 2028 from USD 291 million in 2023, at a CAGR of 6.3% during the forecast period. The growth of this market is majorly driven by the ... Read More
-
Europe Glioma Treatment Market Forecast to 2030 - Regional Analysis - by Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), and End User (Hospital & Clinics and Ambulatory Surgical Center)
... & Clinics and Ambulatory Surgical Center) The Europe glioma treatment market is expected to grow from US$ 959.99 million in 2022 to US$ 1,905.10 million by 2030. It is estimated to grow at a CAGR ... Read More
-
Schizophrenia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... a chronic disorder that profoundly impacts individuals' lives, is characterized by an abnormal interpretation of reality and leads to various behavioral changes, including hallucinations and delusions. Schizophrenia treatment is an ongoing journey, with medications playing ... Read More
-
Franz Cell and Vapometer Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Africa) The global Franz cell and vapometer market reached US $7 Mn in revenue in 2024 and is poised to grow steadily, projecting a market valuation of US $9.11 Mn by 2031. Driving Factors for ... Read More
-
Treatment Syndromes Dementia Movement Disorders Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... and Africa) Leading Pharmaceutical Companies Aim to Address Rising Incidence of Cognitive Defects The global market for the treatment of syndromes related to dementia and movement disorders has witnessed remarkable growth in recent years, as ... Read More
-
Neurology Contract Research Organization Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Africa) The global neurology contract research organization market reached a revenue of US$ 7.9 billion in 2024 and is poised for significant expansion, to attain US$ 13.8 billion by 2031. Rapid Growth Attributed to Increasing ... Read More
-
Attention Deficit Hyperactivity Disorder Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... and Africa) The global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market is poised for substantial expansion, with global revenues reaching approximately US$ 23.3 billion in 2024. The market is expected to reach a valuation of ... Read More
-
Neuropathic Pain Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global neuropathic pain market is on the verge of a substantial growth trajectory, with experts projecting its value to soar from approximately $8.6 billion in 2024 to an estimated $13.5 billion by the end of ... Read More
-
Europe Brain Health Supplements Market Forecast to 2028 - Regional Analysis - by Product (Natural Molecules, Herbal Extract, Vitamins and Minerals), Application (Memory Enhancement, Attention and Focus, Depression and Mood, Sleep and Recovery, Anti-aging and Longevity, Others), Dosage Form (Capsules, Tablets, Others), Distribution Channel (Supermarket and Hypermarket, Drug Store, Online, Others), and Age Category (Adults, Children, Elderly)
... Longevity, Others), Dosage Form (Capsules, Tablets, Others), Distribution Channel (Supermarket and Hypermarket, Drug Store, Online, Others), and Age Category (Adults, Children, Elderly) The Europe brain health supplements market is expected to grow from US$ 1,807.04 ... Read More
-
Europe Homeopathy Market Forecast to 2030 - Regional Analysis - by Source (Plants, Animals, and Minerals), Type (Dilutions, Tinctures, Biochemics, Ointments, Tablets, and Others), Application (Analgesic and Antipyretic, Respiratory, Neurology, Immunology, Gastroenterology, Dermatology, and Others), and Distribution Channel (Homeopathic Clinics, Retail Pharmacies, E-Retailers, and Others)
... and Distribution Channel (Homeopathic Clinics, Retail Pharmacies, E-Retailers, and Others) The Europe homeopathy market was valued at US$ 2,346.30 million in 2022 and is expected to reach US$ 6,859.34 million by 2030; it is estimated ... Read More
-
Europe Radioactive Tracer Market Forecast to 2030 - Regional Analysis - by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others), and End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others)
... Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, ... Read More
-
Fibromyalgia Antidepressants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global revenue from the fibromyalgia antidepressants market reached approximately US$ 520 million in 2024, with a projected compound annual growth rate (CAGR) of 9.7%. The market is expected to reach a valuation of approximately US$ ... Read More
-
Agitation in Delirium Management Market, By Drug Type (First-generation Antipsychotics, Second-generation Antipsychotics, Benzodiazepines), By Route of Administration (Oral, Intramuscular, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... Europe, Middle East & Africa, and Asia Pacific) Delirium is commonly associated with myriad conditions and requires a variety of medications. Early recognition and on-time treatment can help reduce morbidity, length of hospital stay, health ... Read More
-
Personalized Psychiatry Market, By Product Type (Software, Services, EEG Biofeedback, Blood Tests, Wearables, Brain Stimulation Devices, Others), By Condition (Depression & Anxiety, Bipolar Disorder, Addiction, Dementia, ADHD, OCD, Others), By End-User (Hospitals & Clinics, Academic Institutes & Research Centers, Homecare Settings, Specialty Clinics, Diagnostic Laboratories, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Institutes & Research Centers, Homecare Settings, Specialty Clinics, Diagnostic Laboratories, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Personalized Psychiatry Market, By Product Type (Software, Services, EEG Biofeedback, Blood ... Read More
-
Radioactive Tracer Market, By Type (Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers, Others), By Application (Oncology, Cardiology, Neurology, Thyroid, Lymphoma, Endocrinology, Others), By End User (Hospitals, Diagnostic Centers, Cancer Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Latin America, Europe, Asia Pacific, Middle East & Africa) Radioactive Tracer Market, By Type (Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers, Others), By Application (Oncology, Cardiology, Neurology, Thyroid, Lymphoma, Endocrinology, Others), By End User (Hospitals, Diagnostic ... Read More
-
Spain Neurology Procedures Count by Segments and Forecast to 2030
... provides procedure volumes within segments - Dura Substitute Procedures, Hydrocephalus Shunting Procedures, ICP Procedures, Intracranial Stenting Procedures, Minimally Invasive Neurosurgery Procedures, Neurovascular Accessory Procedures and Others The Spain Neurology Procedures report provides key information and ... Read More
-
Europe Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
... and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 ... Read More
-
EU5 ICP Procedures Count and Forecast to 2030
... provides key information and data on - Procedure volume data for ICP Procedures related to the country. Data is provided from 2015 to 2030. Scope EU5 ICP Procedures is segmented as follows - ICP Procedures ... Read More
-
Alzheimer’s Disease Market: Distribution by Type of Treatment (Symptomatic and Disease Modifying), Symptomatic Indications (Dementia, Insomnia and Other Psychological Symptoms) and Geography (North America, Europe and Asia-Pacific), 2021-2030
... characterized by the death of brain cells, eventually leading to memory loss, cognitive dysfunction and dementia. Accounting for 60-70% cases of dementia, Alzheimer’s disease is known to be the sixth leading cause of death in ... Read More
Research Assistance
